ProShare Advisors LLC Purchases 2,633 Shares of Zoetis Inc. (NYSE:ZTS)

ProShare Advisors LLC grew its position in Zoetis Inc. (NYSE:ZTS) by 2.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 109,521 shares of the company’s stock after purchasing an additional 2,633 shares during the period. ProShare Advisors LLC’s holdings in Zoetis were worth $18,987,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Focus Financial Network Inc. ADV bought a new position in shares of Zoetis during the 4th quarter worth approximately $2,159,000. Price T Rowe Associates Inc. MD increased its stake in Zoetis by 31.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after buying an additional 3,244,074 shares during the last quarter. Axiom Investors LLC DE lifted its position in Zoetis by 36.3% during the 4th quarter. Axiom Investors LLC DE now owns 594,474 shares of the company’s stock worth $117,331,000 after buying an additional 158,459 shares in the last quarter. Global Assets Advisory LLC acquired a new position in shares of Zoetis during the 1st quarter worth about $8,831,000. Finally, Franklin Street Advisors Inc. NC grew its holdings in shares of Zoetis by 4.3% in the 1st quarter. Franklin Street Advisors Inc. NC now owns 121,024 shares of the company’s stock valued at $20,478,000 after acquiring an additional 5,035 shares in the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages recently commented on ZTS. Stifel Nicolaus increased their price target on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Wednesday, September 18th. Piper Sandler increased their price objective on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. BTIG Research boosted their target price on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, August 12th. Finally, Argus raised shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Zoetis has an average rating of “Buy” and an average price target of $220.38.

Zoetis Trading Up 0.5 %

ZTS stock opened at $193.59 on Tuesday. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92. The stock has a market cap of $88.33 billion, a price-to-earnings ratio of 37.30, a price-to-earnings-growth ratio of 2.98 and a beta of 0.88. The company has a fifty day moving average price of $185.01 and a two-hundred day moving average price of $174.42. The company has a debt-to-equity ratio of 1.32, a current ratio of 3.45 and a quick ratio of 2.09.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, topping the consensus estimate of $1.49 by $0.07. The business had revenue of $2.36 billion during the quarter, compared to the consensus estimate of $2.31 billion. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. Zoetis’s revenue was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.41 EPS. Equities analysts anticipate that Zoetis Inc. will post 5.84 EPS for the current year.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.